Medline shares fell 8.69% over the past week. The supplied information includes no company-specific news to explain the decline, so its cause is unclear. The latest reported close was US$32.38, near the bottom of the 52-week range.
Investor takeaway: The weekly decline is clear, but the available facts don’t show what caused it or whether it will continue.
Medline fell 8.69% in one week
Advertisement
Medline Inc. Class A Common Stock
MDLN.US
MDLN.US
Medline Inc. Class A Common Stock
WealthAwesomeMarket cap
$45.33B
P/E
86.4x
52W high
$50.88
52W low
$31.49
1W change
-8.69%
Analyst Price Targets
Based on 27 analysts covering MDLN · as of Oct 26, 2026
Wall Street analysts forecast MDLN stock price to rise 36.8% over the next 12 months.
Consensus
Buy4.44 / 5.00
Avg. Target
C$44.31
+36.8% Upside
Previously C$44.42 on Oct 12, 2026
Current Price
C$32.38
Last close
Analyst Breakdown (27 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MDLN's historical volatility
30-Day Vol
32.5%
Annualized
90-Day Vol
47.7%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$27.08
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$30.51 | C$27.27 – C$34.13 |
| 60 trading days | C$28.75 | C$24.53 – C$33.69 |
| 90 trading days | C$27.08 | C$22.30 – C$32.89 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
The shares closed at US$32.38, within a 52-week range of US$31.49 to US$50.88.
Bull case
Medline remains within its 52-week range, and its latest reported volume was above the 20-day average. Neither figure explains the weekly decline or indicates what comes next.
Bear case
The shares fell 8.69% for the week and closed just 5% above their 52-week low. No company-specific news was provided to explain the decline.
What happened: Medline fell 8.69% over the week
Medline’s shares fell 8.69% over the week. They also declined 3.89% in one day, 6.69% over one month, and 20.29% year to date. These figures show how the stock performed, but not why. No company news was supplied. You can follow MDLN.US on the Medline stock page, but the available information doesn’t link the decline to a specific announcement or outside event.
Advertisement
What the numbers show: US$32.38 close near the 52-week low
Medline’s latest reported close was US$32.38, within a 52-week range of US$31.49 to US$50.88. The supplied range-position figure puts the close 5% above the low. The price was 6.5% below its 50-day moving average of US$34.64 and 18.7% below its 200-day average of US$39.85.
Latest volume was 11,132 shares, compared with a 20-day average of 8,430,342. The reported volume ratio was 1.26x. These figures describe trading activity but don’t explain the weekly move. The Medline ratings page also lists fundamentals and analyst information, but those details don’t establish what drove the decline.
What to watch next: no company-specific information supplied
The supplied facts include no company news or other event that explains the decline, and they identify no upcoming catalyst to watch. The price move is clear, but its cause is not. Further company disclosures or updated market data could provide context, but none is included here.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
